Cargando…
MicroRNAs as disease progression biomarkers and therapeutic targets in experimental autoimmune encephalomyelitis model of multiple sclerosis
Multiple sclerosis is an autoimmune neurodegenerative disease of the central nervous system characterized by pronounced inflammatory infiltrates entering the brain, spinal cord and optic nerve leading to demyelination. Focal demyelination is associated with relapsing-remitting multiple sclerosis, wh...
Autores principales: | Martinez, Bridget, Peplow, Philip V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513985/ https://www.ncbi.nlm.nih.gov/pubmed/32246624 http://dx.doi.org/10.4103/1673-5374.280307 |
Ejemplares similares
-
MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression
por: Martinez, Bridget, et al.
Publicado: (2019) -
MicroRNAs as biomarkers in glaucoma and potential therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2022) -
MicroRNAs as biomarkers of diabetic retinopathy and disease progression
por: Martinez, Bridget, et al.
Publicado: (2019) -
MicroRNAs in mouse and rat models of experimental epilepsy and potential therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2023) -
MicroRNAs in Parkinson's disease and emerging therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2017)